Chronic kidney disease (CKD) is prevalent among people with diabetes. Many people with CKD suffer from anemia as a complication. Despite its prevalence in CKD, anemia tends to be an underrecognized and undertreated condition in this population. Since the 1980s, effective treatments to correct anemia have been available. Additionally, newer treatments are on the horizon that have the potential to provide additional therapy options to improve outcomes for patients with anemia in CKD.

This content is only available via PDF.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at